BiomX buys 10% stake in Motomea for $50,000 cash, plans 1,300,000 restricted shares issuance
PHGE•BiomX takes stake in Motomea and secures option to buy control
BiomX bought a 10% stake in Motomea, an electric motor testing and validation systems developer focused on drone propulsion.
Deal terms include a $50,000 cash payment, with a plan to issue 1,300,000 restricted shares to Motomea’s majority owner. Share issuance is subject to regulatory clearance and NYSE approval.
BiomX also secured an option to acquire control of Motomea, subject to due diligence. Option pricing would be based on 2x 2027 net revenue, 4x 2028 EBITDA, then multiplied by 90%.
